title: The use of neoplastic donors to increase the donor pool.
abstract: The aim of the study was to evaluate the experience of the Centre-Sud Transplant Organization (OCST) area using cadaveric donor with neoplastic diseases to evaluate the possibility of transmission to recipients. From January 1, 2003, to December 31, 2010, the neoplastic risk has been reported to be 5.4% (377/4654 referred donors). In 2003, the number of donors with a tumor and their mean age were respectively: 60 (10.3%) and 59.6 ± 19.9; 2004: 33 (5.2%) and 61.4 ± 15.9; 2005: 32 (6%) and 62.8 ± 15.5; 2006: 46 (7%) and 60.7 ± 19.1; 2007: 51 (7%) and 58.9 ± 16; in 2008: 58 (7%) and 59.7 ± 19.6; 2009: 47 (7%) and 57 ± 26; 2010: 49 (7%) and 64 ± 16. The organ most affected by tumor has been the central nervous system (18%). The tumor was diagnosed before in 325 (86%) cases, versus during organ retrieval in 48 (12.7%) donor operations but before, which four cases (1%) occured after transplantation. According to the histological types and grades, 28 evaluated donors (8.2%) were suitable for transplantation. The histological types were: thyroid carcinoma (n = 3); prostate carcinoma (n = 8), renal clear cell carcinoma (n = 7), oncocytoma (n = 1), meningiomas (n = 2), dermofibrosarcoma (n = 1); verrucous carcinoma of the vulva (n = 1), colon adenocarcinoma (n = 1), grade II astrocytoma (n = 1), adrenal gland tumor (n = 1), gastric GIST (n = 1), oligodendroglioma (n = 1). Forty-five organs were retrieved (22 livers, 19 kidneys, 3 hearts, and 1 pancreas) and transplanted into 44 recipients with 1 liver-kidney combined transplantation. Four recipients died due to causes not related to the tumor. No donor-transmitted tumor was detected among the recipients. Donation is absolutely not indicated in cases of tumors with high metastatic potential and high grades. Performing an accurate evaluation of the donor, taking into account the histological grade, currently can allow, organ retrieval and transplantation with an acceptable risk.
authors.affiliation: Interregional Transplant Centre, Organizzazione Centro Sud Trapianti c/o Sapienza Università di Roma-Umberto I Policlinico di Roma, Roma, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Fiaschetti
authors.forename: R
authors.initials: R
authors.lastname: Pretagostini
authors.forename: D
authors.initials: D
authors.lastname: Stabile
authors.forename: D
authors.initials: D
authors.lastname: Peritore
authors.forename: A
authors.initials: A
authors.lastname: Oliveti
authors.forename: F
authors.initials: F
authors.lastname: Gabbrielli
authors.forename: S
authors.initials: S
authors.lastname: Cenci
authors.forename: A
authors.initials: A
authors.lastname: Ricci
authors.forename: F
authors.initials: F
authors.lastname: Vespasiano
authors.forename: W F
authors.initials: WF
authors.lastname: Grigioni
mesh_terms: D002102:Cadaver; D006801:Humans; D007558:Italy; D009369:Neoplasms / Q000145:classification; D014019:Tissue Donors / Q000706:statistics & numerical data*